ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,332, issued on Dec. 2, was assigned to AVEO Pharmaceuticals Inc. (Boston).

"Anti-ERBB3 antibodies" was invented by Sylvie Vincent (Somerville, Mass.), William M. Winston Jr. (Marlborough, Mass.), Fang Wang (Belmont, Mass.), Solly Weiler (Newton, Mass.), Kristan Meetze (Lexington, Mass.), Lyne Breault (Roslindale, Mass.), Steve Bottega (Cambridge, Mass.), Ting Chen (Acton, Mass.), Michael DePrima (Somerville, Mass.), Christina Fleet (Melrose, Mass.), Steven Tyler (Boston), Jin-Kyeung Woo (Newton, Mass.) and Jeno Gyuris (Lincoln, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Monoclonal antibodies that bind and inhibit activation of epidermal gro...